Lipid Accumulation Product Better Predicts Metabolic Status in Lean Polycystic Ovary Syndrome than that by Visceral Adiposity Index

BACKGROUND: Both visceral adiposity index (VAI) and lipid accumulation product (LAP) can be used to assess insulin resistance (IR) and metabolic syndrome (MetS) which are required for management of even lean polycystic ovary syndrome (PCOS) (body mass index [BMI] <23 kg/m(2)). AIM: This study was...

Descripción completa

Detalles Bibliográficos
Autores principales: Banu, Hurjahan, Morshed, Md. Shahed, Sultana, Tania, Shah, Sukanti, Afrine, Shazia, Hasanat, M. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9053338/
https://www.ncbi.nlm.nih.gov/pubmed/35494190
http://dx.doi.org/10.4103/jhrs.jhrs_114_21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9053338/
https://www.ncbi.nlm.nih.gov/pubmed/35494190
http://dx.doi.org/10.4103/jhrs.jhrs_114_21

Ejemplares similares